# US 2023/0263757 A1 · Disinfecting wipe kit for central venous access devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0263757 A1
- Document ID: US20230263757A1
- Status: Published application
- Kind: A1
- Application number: 18/112,625
- Filed: 2023-02-22
- Published: 2023-08-24
- Earliest claimed: 2022-02-22
- Assignees: SterileCare Inc.
- Applicants: SterileCare Inc.
- Inventors: Karen Mueller
- Web page: https://patentgrep.com/patent/US20230263757A1

## CPC

- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A01N 25/34: Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
- A01N 31/02: Acyclic compounds
- A01N 47/44: Guanidine; Derivatives thereof
- A01P 1/00: Disinfectants; Antimicrobial compounds or mixtures thereof
- A61K 31/045: Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K 31/155: Amidines ([IMAGE cpc-sch-A61K-1029.gif]), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A61L 2/18: Liquid substances
- A61L 2101/32: Organic compounds
- A61M 25/002: {Packages specially adapted therefor (combined with means for introducing catheters, e.g. dispensers, A61M25/0113); catheter kit packages (for surgical articles A61B50/30)}
- A61M 2025/0019: {Cleaning catheters or the like, e.g. for reuse of the device, for avoiding replacement}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Provided herein are compositions and solutions containing tetrasodium EDTA, ethanol, and chlorhexidine, and optionally taurolidine, heparin, or a thrombolytic agent. The compositions may be disposed on a cleaning wipe to provide broad-spectrum antimicrobial activity on planktonic and biofilm cells of clinically relevant pathogens. Also provided herein is a peripheral line placement kit containing the compositions and solutions.

## Claims

### Claim 1

A cleaning wipe kit, the kit comprising:
at least one first wipe, wherein the first wipe comprises a first composition comprising 1-15% (w/v) tetrasodium EDTA and ethanol, and wherein the composition has a pH of at least 9.5; and
at least one second wipe, wherein the second wipe comprises a second composition comprising 1.0-15% (w/v) tetrasodium EDTA, ethanol, and chlorhexidine, and wherein the composition has a pH of at least 9.5.

### Claim 2 (depends on 1)

The cleaning wipe kit of claim 1, wherein the first composition comprises 10-60% (w/v) ethanol.

### Claim 3 (depends on 1)

The cleaning wipe kit of claim 1, wherein the first composition comprises 3% (w/v) tetrasodium EDTA and 20-25% ethanol.

### Claim 4 (depends on 3)

The cleaning wipe kit of claim 3, wherein the first composition comprises 20% (w/v) ethanol.

### Claim 5 (depends on 1)

The cleaning wipe kit of claim 1, wherein the second composition comprises 10-60% (w/v) ethanol.

### Claim 6 (depends on 1)

The cleaning wipe kit of claim 1, wherein the second composition comprises 0.5-6% (w/v) chlorhexidine.

### Claim 7 (depends on 6)

The cleaning wipe kit of claim 6, wherein the second composition comprises 3% (w/v) tetrasodium EDTA, 20-25% (w/v) ethanol, and 1-2% (w/v) chlorhexidine.

### Claim 8 (depends on 7)

The cleaning wipe kit of claim 7, wherein the second composition comprises 20% (w/v) ethanol.

### Claim 9 (depends on 1)

The cleaning wipe kit of claim 1, wherein the at least one first wipe exudes the first composition and the at least one second wipe exudes the second composition.

### Claim 10 (depends on 1)

The cleaning wipe kit of claim 1, associated with a catheter.

### Claim 11 (depends on 1)

The cleaning wipe kit of claim 1, wherein the at least one first wipe is associated with insertion of a catheter.

### Claim 12 (depends on 1)

The cleaning wipe kit of claim 1, wherein the at least one second wipe is associated with service of a catheter.

### Claim 13

A peripheral line placement kit comprising:
a peripheral line; and
a solution chamber in communication with the peripheral line, wherein the solution chamber is configured to dispense a first disinfecting solution comprising 1-15% (w/v) tetrasodium EDTA, ethanol, chlorhexidine, and at least 1% (w/v) taurolidine, and wherein the composition has a pH of between 6.5 and 7.5 and is biocompatible in a bloodstream.

### Claim 14 (depends on 13)

The kit of claim 13, further comprising at least one additional product selected from a flush solution, a lock solution, a swab, a wet wipe, and a cleaning product, wherein the additional product comprises a second disinfecting solution comprising least three of tetrasodium EDTA, ethanol, taurolidine, and chlorhexidine, and wherein a composition of the second disinfecting solution is different from a composition of the first disinfecting solution.
